NKCFO LLC
RPRX icon

NKCFO LLC’s Royalty Pharma RPRX Stock Holding History

NKCFO LLC’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$123K Buy
+2,100
New +$124K 0.04% 77

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
New South Capital Management
New South Capital Management Memphis, Tennessee $1.53B AUM 36.31% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

NKCFO LLC's RPRX Position: Q3 2026 in Review

NKCFO LLC opened a new position in Royalty Pharma (RPRX) in Q3 2026: 2,100 shares worth $123K. The stake represents 0.04% of the portfolio and ranks #77 among its holdings.

347 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • NKCFO LLC held 2,100 shares of Royalty Pharma worth $123K as of Q3 2026.
  • Royalty Pharma was a new NKCFO LLC position in Q3 2026.
  • Royalty Pharma made up 0.04% of NKCFO LLC's portfolio in Q3 2026, its #77 holding.
  • 347 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on NKCFO LLC's 13F filing for Q3 2026, filed 4 Nov 2026.